JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2013, 62(5):223-226

Influence of temperature and concentration of a surfactant on pharmaceutical availability

Petra Herdová1,*, Zuzana Vitková1, Jarmila Oremusová2, Alexandra Kodadová1
1 Univerzita Komenského v Bratislave, Farmaceutická fakulta, Katedra galenickej farmácie
2 Univerzita Komenského v Bratislave, Farmaceutická fakulta, Katedra fyzikálnej chémie liečiv

This study aimed to analyze the influence of surfactant concentration and temperature on drug liberation from hydrogels and their flow properties. The surfactant benzethonium chloride (BZCl) was used in concentrations of 0.01, 0.1 and 0.5 % (w/w), while the drug chlorhexidine dihydrochloride (CHX) was used in a concentration of 0.1 % (w/w). Chitosan (CHIT) in 2.5 % (w/w) concentration was used as a gel-creating substance. The drug and surfactant liberation were evaluated within the temperature range of 25-40 °C. The largest amounts of both of them were liberated at the temperature of 40 °C. Through the concentration changes it was possible to obtain statistically significant differences (P < 0.05) between the liberation of CHX and BZCl. An analysis of the flow properties revealed that the character of the plastic system was not influenced by the changing concentration of the surfactant. The experimental results led to the conclusion that the optimum composition of the gel was as follows: 2.5 % (w/w) CHIT + 0.1 % (w/w) CHX + 0.01 % (w/w) BZCl.

Keywords: chlorhexidine dihydrochloride; benzethonium chloride; chitosan; liberation; critical micelle concentration
Grants and funding:

Výskum bol podporený grantami FAF UK/3/2013, UK/101/2013, VEGA 1/0024/11.

Received: September 9, 2013; Accepted: September 19, 2013; Published: May 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Herdová P, Vitková Z, Oremusová J, Kodadová A. Influence of temperature and concentration of a surfactant on pharmaceutical availability. Čes. slov. farm. 2013;62(5):223-226.
Download citation

References

  1. Rangel-Yagui C. O., Pessoa A., Tavares L. C. Micellar Solubilization of Drugs. J Pharm Pharmaceut Sci 2005; 8(2), 147-165.
  2. Bartovská L. Fyzikální chemie povrchových a koloidných soustav. 5 vyd. Praha: VŠCHT 2005; 244, 186-191.
  3. Kim H-U., Lim K-H. A model on the temperature dependence of critical micelle concentration. Colloids and Surfaces A: Phys. Chem. Engin. Aspects, 2004; 235(1-3), 121-128. Go to original source...
  4. Chen L-J., Lin S-Y., Huang C.C., Chen E. M. Temperature dependence of critical micelle concentration of polyoxyethylenated non- ionic surfactants. Colloids and Surfaces A: Phys. Chem. Engin. Aspects,1998; 135(1-3), 175-181. Go to original source...
  5. Schramm L. L., Stasiuk E. N., Marangoni D. G. Surfactants and their applications. Annu. Rep. Prog. Chem., Sect. C, 2003; 99, 3-48. Go to original source...
  6. http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=162180433&loc=es_rss#x395[cit. 3.9.2013]
  7. http://cameochemicals.noaa.gov/chemical/19856 [cit. 26.8.2013]
  8. NTP Toxicology and Carcinogenesis Studies of Benzethonium Chloride (CAS No. 121-54-0) in F344/N Rats and B6C3F1 Mice (Dermal Studies). Natl Toxicol Program Tech Rep Ser. 1995; 438, 1-220.
  9. http://www.ncbi.nlm.nih.gov/pubmed/12595925 [cit. 20.8.2013]
  10. Kiselovičová M. Štúdium interakcií katiónového tenzidu s vybranými liečivami (lokálne anestetiká). Diplomová práca. Bratislava: Univerzita Komenského, Farmaceutická fakulta, 2012; 62.




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.